The publication of several studies using cardiac magnetic resonance imaging raised public fears over increased risk to the heart in patients following infection with COVID-19. More
Speeding the process could save thousands of lives, but some say it might also make it easier for the White House to push regulators to clear an unproven vaccine before Election Day. More
Randomized trials of psychotherapy often include "spin" to look more positive and use unethical research practices like outcome switching. More
You’d need a pretty big, stiff broom to sweep away all of the hype dished out by the Trump Administration as it announced an Emergency Use Authorization for convalescent plasma – the liquid component of blood that may be tapped for disease-fighting antibodies from people who’ve been infected with COVID-19. More
How much freedom should front-line clinicians have in treating Covid-19 patients with unproven drugs? The question opened up a civil war in some hospitals. More
Perspective from The New England Journal of Medicine — Covid-19 — A Reminder to Reason More
Covid-19 makes it difficult to practice evidence-based medicine and just as hard to make decisions about the small questions that dictate day-to-day life. More
Without the underlying data, promising vaccines and treatments are impossible to evaluate. More
Misinformation about the pandemic is like COVID-19 itself: highly contagious, destructive, and with no known treatment or vaccine. More
Gilead Sciences Inc’s shares surged 16% in after hours trading on Thursday following a media report detailing encouraging partial data from trials of the U.S. company’s experimental drug remdesivir in severe COVID-19 patients. More